Showing results (111-120 of 686) with videos related to
Sort By:
Pageof 69
The American Journal of Cardiology|November 11, 1998
Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysisS C Reimold, W H Maisel, E M AntmanArchives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1983
Nifedipine therapy for coronary vasospasmP H Stone, E M Antman, J E MullerCoronary Artery Disease|December 22, 1999
Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarctionE M Holper, R P Giugliano, E M AntmanJournal of the American College of Cardiology|September 1, 1983
Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade de pointesB H Lewis, E M Antman, T B GraboysJournal of Personalized Medicine|April 3, 2021
Data from Digital Health Devices Informs Ideal Cardiovascular HealthJane A Leopold, Roger B Davis, Elliott M AntmanCancer|November 15, 1982
Multimodality therapy in the management of angiosarcoma of the breastK H Antman, J Corson, J Greenberger, et al.American Heart Journal|January 5, 2002
Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromesMarc Cohen, Elliott M Antman, Sabina A Murphy, et al.Controlled Clinical Trials|October 1, 1996
Uncertainty of the time of first significance in random effects cumulative meta-analysisC S Berkey, F Mosteller, J Lau, et al.Journal of the American College of Cardiology|September 15, 2000
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarctionJ S Alpert, K Thygesen, E Antman, et al.The American Journal of Cardiology|September 16, 1998
Rationale for the management of coronary syndromes with low-molecular-weight heparinsE Gurfinkel, J Fareed, E Antman, et al.Pageof 69